Dual - functional cRGD/pH - sensitive liposomes loaded with sorafenib: a novel therapeutic approach for hepatocellular carcinoma

索拉非尼 体内分布 肝细胞癌 化学 脂质体 癌症研究 药物输送 治疗指标 药品 药理学 纳米载体 毒品携带者 分布(数学) 分散性 靶向给药 治疗效果 Zeta电位 肽 肝癌 纳米囊 体内 细胞凋亡 阿霉素 内化
作者
Xia Yang,Guangchun Sun,Xiaoyu Zhou,Qing Liang,Jianxing Liu
出处
期刊:Frontiers in nanotechnology [Frontiers Media]
卷期号:8
标识
DOI:10.3389/fnano.2026.1760783
摘要

Background Sorafenib, a first-line treatment for advanced hepatocellular carcinoma (HCC), is severely limited by its low oral bioavailability, lack of tumor specificity, and dose-limiting systemic adverse effects. Nanocarrier-based delivery systems, particularly liposomes, offer a promising strategy to overcome these limitations. Methods We developed a multifunctional liposomal system co-modified with a cyclic RGD (cRGD) peptide and pH-sensitive components (cholesteryl hemisuccinate, CHEMS) for sorafenib delivery (cRGD-pH-Lipo/Sor). The physicochemical properties, drug release profile, stability, and biosafety of this formulation were thoroughly characterized. Its targeting efficiency, cellular uptake, and antitumor efficacy were evaluated in both in vitro (Huh7 and HepG2 cells) and in vivo (Huh7-xenograft nude mice) models using techniques including HPLC, fluorescence imaging, CCK-8 and in vivo imaging system (IVIS). Results The optimized cRGD-pH-Lipo/Sor exhibited a uniform particle size distribution (116.73 ± 1.07 nm, polydispersity index of 0.224 ± 0.0017), negative zeta potential (−22.2 ± 3.50 mV), high encapsulation efficiency (84.1%), and a desirable pH-responsive drug release profile (cumulative release: 73.2% at pH 5.0% vs. 38.4% at pH 7.4). In vitro , cRGD-pH-Lipo/Sor demonstrated significantly enhanced cellular uptake in HCC cells compared to free sorafenib and non-targeted liposomes, attributable to cRGD-mediated active targeting and pH-triggered release. In vivo imaging and biodistribution studies confirmed the superior tumor accumulation of cRGD-pH-Lipo. Most importantly, in a xenograft mouse model, cRGD-pH-Lipo/Sor achieved the most potent tumor growth inhibition without inducing significant systemic toxicity, as evidenced by body weight monitoring, serum biochemical analysis, and histopathological examination. Conclusion The cRGD-modified, pH-sensitive liposomal platform effectively addresses key pharmacological drawbacks of sorafenib. It enhances tumor-targeted delivery, promotes intracellular drug release, and significantly improves the therapeutic index, presenting a promising novel strategy for the systemic treatment of advanced HCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
东方诩完成签到,获得积分10
1秒前
1秒前
ne完成签到 ,获得积分10
1秒前
无私的犀牛完成签到,获得积分10
1秒前
咪咪好咪咪的应助被xudaniel采纳,获得10
1秒前
1秒前
花开富贵完成签到 ,获得积分10
2秒前
研友_rLmMYL完成签到,获得积分10
3秒前
nan完成签到,获得积分10
3秒前
4秒前
4秒前
小小小完成签到,获得积分10
4秒前
WSK发布了新的文献求助10
4秒前
万能图书馆的应助被arniu2008采纳,获得10
4秒前
4秒前
无奈狗完成签到,获得积分10
5秒前
piao完成签到,获得积分10
5秒前
MrChew完成签到 ,获得积分10
6秒前
香蕉觅云的应助被sukiii采纳,获得10
6秒前
7秒前
kiana完成签到,获得积分10
7秒前
钢筋炒煤球完成签到,获得积分10
8秒前
XF完成签到,获得积分10
8秒前
yinzhang5完成签到,获得积分10
8秒前
含蓄的之云完成签到,获得积分10
8秒前
全程都v回复v完成签到,获得积分10
8秒前
冷傲太英完成签到,获得积分10
8秒前
殷勤的帽子完成签到,获得积分10
9秒前
帅气香岚完成签到,获得积分20
9秒前
美好含巧完成签到,获得积分10
10秒前
Steve完成签到,获得积分10
10秒前
ffiu完成签到,获得积分10
10秒前
Skilixta完成签到,获得积分10
10秒前
吴煜阳完成签到,获得积分10
10秒前
Jane完成签到,获得积分10
11秒前
11秒前
Faith完成签到,获得积分10
11秒前
Ohh完成签到,获得积分10
11秒前
斯文大霖完成签到,获得积分10
11秒前
不善言辞的热心网友完成签到 ,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173580
求助须知:如何正确求助?哪些是违规求助? 9565737
关于积分的说明 21782083
捐赠科研通 7767775
什么是DOI,文献DOI怎么找? 3431604
关于科研通互助平台的介绍 2555855
邀请新用户注册赠送积分活动 2476870